Amboss
AMBOSS is a powerful learning and clinical decision support tool striving to empower physicians across the globe to provide the best possible care. Since our launch in 2012, we've used the latest in cutting-edge technology to create the most comprehensive study and reference guide on the market and revolutionized the way physicians and medical students acquire their know-how. By 2017, we transformed the learning experience for 95% of the German market and launched our international platform. In 2019, our hard work secured €30M in Series B funding to expand our products and their reach. Today, we continue to find new ways to innovate and establish ourselves to make a global impact. After being named a Top 10 Health & Science company to watch in 2021 by Business Punk, it is clear that we are not the only ones who are excited about the future of AMBOSS.
Amboss
AMBOSS is a powerful learning and clinical decision support tool striving to empower physicians across the globe to provide the best possible care. Since our launch in 2012, we've used the latest in cutting-edge technology to create the most comprehensive study and reference guide on the market and revolutionized the way physicians and medical students acquire their know-how. By 2017, we transformed the learning experience for 95% of the German market and launched our international platform. In 2019, our hard work secured €30M in Series B funding to expand our products and their reach. Today, we continue to find new ways to innovate and establish ourselves to make a global impact. After being named a Top 10 Health & Science company to watch in 2021 by Business Punk, it is clear that we are not the only ones who are excited about the future of AMBOSS.
TL;DR
Founded: 2012 (founded by physicians)
Product: Integrated medical knowledge platform: interactive Library, high-yield Question Bank, and point-of-care clinical tools
Scale: More than 1M healthcare professionals in 180+ countries
Team size: Approximately 1,000 employees
Offices: New York, Berlin, Cologne, Cagliari
€240M financing announced 2025-03-25 with KIRKBI, M&G Investments and Lightrock
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Medical education and point-of-care clinical decision support
Founded
2012
Industry
IT Services and IT Consulting
Funding Track Record
€30M
Target Global and existing investors participated
€240M
Company converted to a European stock corporation (SE); participation from existing shareholders; financing positioned to support international expansion and broader healthcare professional offerings
Investor Signal
“Secured large strategic financing in 2025 from long-term institutional investors (KIRKBI, M&G Investments, Lightrock) alongside participation from existing shareholders, indicating strong institutional backing for international growth.”